19 Mar
Innovative Cancer Therapy for Tomorrow
Clofarabine in Adult Acute Myelogenous Leukemia Presenter: Stefan Faderl, MD, Associate Professor, University of Texas MD Anderson Cancer Center, Houston, Texas The standard therapy for acute myelogenous leukemia (AML) continues to be based on cytarabine (ara-C, DepoCyt, Enzon), typically in combination with anthracyclines such as idarubicin (Idamycin, Pfizer) or daunorubicin (Cerubidine, Bedford). Although 60% to [...]